From a scientific point of view and for publication purposes, it therefore seems important to study the metabolism of iron and in particular to define its conditions of absorption, metabolism, elimination and storage in the body at course of advanced renal failure. The study will follow the evolution of hormones regulating iron metabolism and put into perspective their links with phosphocalcic and hepatic metabolisms as well as inflammation in hemodialysis patients. The main objective of this program is to study the evolution of hepcidin and erythroferrone levels in hemodialysis patients. These two biomarkers regulating iron metabolism are not performed routinely in dialysis centers and are not listed in the nomenclature.
Study Type
OBSERVATIONAL
Enrollment
200
15 mL of blood to follow the evolution of hepcidin and erythroferrone levels
Hôpital Privé Claude Galien
Quincy-sous-Sénart, France
RECRUITINGconcentration of the two main markers concerning iron metabolism: hepcidin (ng/ml) and erythroferone (ng/ml).
These will be dosed twice over a year of dialysis and for 5 years
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.